Additionally, the combined expression of miR-186 and its downstream target PTTG1 (pituitary tumor-transforming 1) has shown predictive value for tumor infiltration and invasion in colorectal neuroendocrine tumors, with detection possible through non-invasive blood and stool tests (34). This evidence concerns the gene PTTG1 and neoplasm.